Semi-Annual Consolidated Statement Of Cash Flows

AFC-HD AMS Life Science Co.,Ltd. - Filing #7267231

Concept As at
2025-02-28
2024-09-01 to
2025-02-28
As at
2024-08-31
As at
2024-02-29
2023-09-01 to
2024-02-29
As at
2023-08-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,089,822,000 JPY
92,280,000 JPY
Interest and dividends received
10,759,000 JPY
5,210,000 JPY
Interest paid
-86,125,000 JPY
-39,567,000 JPY
Income taxes paid
-448,570,000 JPY
-322,770,000 JPY
Net cash provided by (used in) operating activities
565,886,000 JPY
-264,847,000 JPY
Cash flows from investing activities
Purchase of investment securities
-73,595,000 JPY
-418,633,000 JPY
Proceeds from sale of investment securities
86,796,000 JPY
537,622,000 JPY
Other, net
-42,030,000 JPY
73,893,000 JPY
Net cash provided by (used in) investing activities
-1,940,512,000 JPY
-1,354,435,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
727,233,000 JPY
643,000,000 JPY
Repayments of long-term borrowings
-162,872,000 JPY
-308,318,000 JPY
Purchase of treasury shares
-13,230,000 JPY
JPY
Dividends paid
-210,427,000 JPY
-208,898,000 JPY
Net cash provided by (used in) financing activities
594,347,000 JPY
707,537,000 JPY
Other, net
-1,125,000 JPY
59,288,000 JPY
Effect of exchange rate change on cash and cash equivalents
-47,953,000 JPY
4,095,000 JPY
Net increase (decrease) in cash and cash equivalents
-828,231,000 JPY
-907,650,000 JPY
Cash and cash equivalents
11,242,319,000 JPY
12,070,550,000 JPY
10,154,370,000 JPY
11,062,021,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.